Galderma Campaign “Proof in Real Life”: Patients Tell their Stories One Year Later
7.10.2016 05:00 | Business Wire
In 2015, Sharon Stone, signed on to the “Proof in Real Life” campaign to help Galderma challenge common misconceptions of aesthetic treatments.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161006006286/en/
(Photo: Business Wire)
Galderma & Sharon Stone unveiled the natural-looking results of Restylane fillers and Restylane Skinboosters in a unique real-life format in Berlin, Germany. The Galderma Proof in Real Life campaign launch event saw ten pairs of identical twins take part in a unique challenge. One twin from each pair received a bespoke treatment plan which consisted of treatments with Restylane fillers, Restylane Skinboosters, or a combination of both. Twelve months on from the original campaign, both twins have now been treated.
Galderma met with them and asked them about their expectations, the results and their feelings, having all received the treatment.
Valuable Insights from the Twins and Aesthetic Professionals
To document their reactions, Galderma has launched a new film containing interviews with a number of the twins as well as insights from leading industry experts, featuring Plastic Surgeons, Dermatologists and Aesthetic Physicians.
“It was quite an amazing journey for all of us, to be honest”, said Dr. Kuldeep Minocha, the aesthetic practitioner based in London, UK, who performed the treatments. “What was interesting is that all bar one of the sets of twins were treatment naïve. So, they hadn’t had any kind of injectables before. This was a very new step for them.
“So we took a lot of time in understanding what they felt about their skin and skin ageing. We educated them a little bit about the use of injectables, and talked to them about the various properties of what we could do with fillers to try and improve their skin but maintaining things as natural as possible. I think that was the biggest key, particularly when you’re treating patients who are naïve and who have not had any previous treatment and they don’t want too much change. So everything we want to do is to refresh the skin and make them look like the best versions of themselves.”
In the interview, Kelly, one of the twins treated in 2015, described the reactions.
“When I looked in the mirror after my treatments, I was really happy with the results. I was amazed how natural my skin looked, how natural my overall look was, so I was very pleased with what I saw, definitely. A lot of people said, ’You look really fresh, youthful, you’re glowing.’”
Agreement on the Importance of Natural Looking Results
One of the featured elements of the campaign was the focus on achieving natural- looking results. Dr. Van Park, a leading Cosmetic Physician from Sydney, Australia gave her views on patient expectations. “A natural looking result, to me, is undetectable. In my experience, when patients come and see me, they expect to become a better version of themselves. To look the best they can for as long as they can, rather than trying to look 20 years younger. They just want to look fresher and less tired.”
The interviewed professionals agree on this point. Dr. Marie-Thérèse Bousquet, who has worked with aesthetic medicine since 1992, says, “Natural beauty is essential for my patients and for me. They do not want their treatment to be seen.” She continues, “To achieve natural looking results, here is my way of working: I associate different treatments; I never over-correct; I am able to say “no” to the patient. My goal is an improvement of the face without being excessive.”
“Proof in Real Life” of Confidence and Self-Esteem
Another key focus area in the Proof In Real Life Campaign was learning about how patients felt about themselves after treatment.
“Patients often come to me saying they want something to make them look better, but the reality is that they’re asking for something to make them feel better,” says Dr. Steven Dayan, a facial Plastic Surgeon from Chicago, USA. “Perfection of beauty does not equal happiness. What we are actually trying to achieve is to make people feel better about themselves. That’s self-esteem.”
One of the twins, Amie, summed up her experience very eloquently: “I think the main thing people noticed in me after treatment was the confidence I had in myself.”
“The ‘Proof in Real Life’ Campaign has provided some remarkable insights into aesthetic treatments, how achievable and natural-looking these results can be,” said Anne-Sophie Copin, from Galderma. “It has highlighted the important positive effects that aesthetic treatment seem to have, not only on the outside, but also for patients’ confidence, well- being and self-esteem.”
Dr. Steven Dayan sees these kinds of results as central: “This all falls within the realm of what we do as Aesthetic Physicians.” Dr. Dayan concludes, “Restylane has been around for 20 years; it has been on the market in the U.S. since 2003. I’m very comfortable with Restylane and all its capabilities – we understand [Restylane] very well.”
Experience for yourself how the twins reacted. Watch Galderma’s film “Proof in Real Life, Twelve Months On”: www.restylane.com
Dating back to 1961, Galderma is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.
Restylane is a range of Hyaluronic Acid (HA) dermal fillers for facial aesthetic treatments to efficiently reduce lines, folds and wrinkles, create fuller lips, enhance contours and facial volume, as well as improve skin quality, structure and elasticity. Restylane has an established safety profile based on over 2 decades of experience and extensive clinical documentation.
Today, with over 28 million treatments worldwide, Restylane is known for natural-looking results with long-lasting effects and high patient satisfaction. The Restylane range is designed to complement the varying stages of facial aging for truly individualized treatments that suit all patient needs.
Within the Restylane range there are two main product ranges:
- Restylane fillers, designed to enhance and restore facial features, from targeted superficial filling of wrinkles to deeper facial shaping and contouring.
- Restylane Skinboosters, a progressive approach to improved skin condition, designed to restore the skin’s hydrobalance and refresh the appearance.
“Proof in Real Life”, Twelve Months On: www.restylane.com
Galderma Launches “Proof in Real Life”: http://proofirl.com/nu/
As for all injection treatments using hyaluronic acid dermal fillers, side effects may occur in association with treatment. These side effects are usually mild to moderate, and include transient reactions such as redness, pain, swelling, bruising and/or bumps at the injection sites. Please consult your physician for additional information.
The reactions mentioned in this release are based on the individual’s own experiences and opinions and may not be what others will experience.
“Proof in Real Life” is not being activated in the US.
Restylane, Restylane Skinboosters and Galderma are trademarks of Nestlé Skin Health S.A.
© Nestlé Skin Health S.A. June 2016
Head of PR & Communication
Aesthetic & Corrective Business
Mobile: +46 768 98 1106
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
The Valence Group Issues Fairness Opinion to SK Capital in Connection with Archroma18.8.2017 13:30 | Pressemelding
The Valence Group has provided a fairness opinion to SK Capital Partners, LP in connection with its recapitalization of Archroma, including investments made by various affiliates of SK Capital. Terms of the transaction were not disclosed. About SK Capital SK Capital is a private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. The firm builds strong and growing businesses that generate substantial long-term value for its investors. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing companies with improved strategic positioning, growth, profitability and risk profiles. The firm currently has approximately $1.9 billion of assets under management and its portfolio companies generate revenues of over $5.0 billion annually and employ approximat
Biker Summer 2017 campaign: What’s happening during Biker Summer 2017? Moto-tyres.co.uk is giving away exciting prizes!18.8.2017 09:22 | Pressemelding
Whether it’s a short weekend break or a long-distance tour – once again this year Moto-tyres.co.uk is asking bikers from 10 countries about their dream destinations and longest journeys as part of its “Biker Summer 2017” campaign. To ensure than nothing gets in the way of your next tour, the two-wheeler tyre store from Delticom, Europe’s leading online tyre dealer, is entering anyone who completes the survey before 30 September 2017 into a prize draw to win some great biking accessories. Simply answer three short questions about your plans for bike tours this year (don’t forget to provide your name and email address), and with a bit of luck, you might win one of these great prizes. Up for grabs are a GARMIN motorbike GPS system, a GoPro camera with helmet bracket and five 200-Pound vouchers for new motorbike tyres from the online store – thanks to the product range at Moto-tyres.co.uk, eve
Lenovo Continues to Gain Momentum in First Quarter FY 2017/1818.8.2017 00:04 | Pressemelding
Behind the strength of its 3-wave strategy, Lenovo’s business transformation continued to gain traction during the first quarter, delivering solid profitability in its core PC and smart devices business, and revenue and profit improvements in targeted growth areas, including the data center and mobile businesses. Fueled by new investments in people and products, Lenovo’s Data Center Group (DCG) introduced the most comprehensive product lineup in its history, with the new ThinkSystem and ThinkAgile portfolio, and continued to build out its end-to-end sales organization. Similarly, Lenovo’s Mobile Business Group launched significant new products led by the Moto Z2 Force, available now on all major U.S. carriers, and ramped up its branding efforts worldwide. “In the first quarter this fiscal year, we had stable performance as we executed our 3-wave strategy with commitment. We
Spirent Tests Wi-Fi Network Performance with O2 at the Coca-Cola London Eye17.8.2017 15:57 | Pressemelding
Spirent Communications plc (LSE:SPT), today announced its Landslide E10 network test platform has been used with O2 to validate the Wi-Fi network performance and capacity at the Coca-Cola London Eye, before the launch of a new smartphone application last month. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170817005758/en/ Spirent Landslide E10 helped O2 validate Wi-Fi performance and capacity at the Coca-Cola London Eye, before the launch of a new smartphone application last month. (Photo: Busines Wire) Merlin Entertainments plc, operator of the London Eye, wanted to measure its Wi-Fi network performance, to ensure its infrastructure could provide an excellent experience for users of the new app, which puts increased demands on the Wi-Fi network. “The London Eye is a global attractio
Watch BizWireTV: A Camera You Can Wear and Krispy Kreme’s Famous Donuts Get Eclipsed with Chocolate17.8.2017 12:08 | Pressemelding
On BizWireTV, catch some Quick Biz Hits and see the latest in Star Power. Also see what’s happening in the startup world with the Accelerator Report, featuring the VC Watch and this week’s Startup Standout. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170817005305/en/ BizWireTV is hosted by Jordyn Rolling (Photo: Business Wire Now you can watch BizWireTV, and the latest breakthroughs in tech from the biggest brands, on any screen you want by downloading the new app through the Apple TV and iPhone App Store and Google Play for Android devices. Top of the Wire Introducing FrontRow: the camera re-invented. Watch BizWireTV to see more disruptors as well as the top 5 trending stories of the week! A core c
PsiOxus Therapeutics Announce Two New Board Appointments: New Board Appointments Strengthen Company’s US Presence17.8.2017 07:00 | Pressemelding
PsiOxus Therapeutics, Ltd. (PsiOxus) today announced the appointment of Charles Rowland and Duncan Higgons to the Board of Directors as part of an ongoing drive to expand in the US. Charles Rowland was most recently the President and Chief Executive Officer (CEO) of Aurinia Pharmaceuticals, a clinical stage pharmaceutical company focused on the global lupus nephritis market. Prior to this, he served as the Vice President and Chief Financial Officer (CFO) of ViroPharma, during which time the company grew into a global biopharmaceutical business with $500 million in annual revenues until it was acquired by Shire plc for $4.2 billion. Before joining ViroPharma, Mr. Rowland was executive Vice President, CFO, and interim co-CEO, for Endo Pharmaceuticals. In his earlier career, Charles held finance and operational positions at Biovail Pharmaceuticals, Breakaway Technologies, Pharmacia
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom